Skip to content

To observe the effect of in vitro plasma lipid adsorption and filtration technology for stroke on the visual acuity of patients with acute cerebral infarction

To observe the effect of in vitro plasma lipid adsorption and filtration technology for stroke on the visual acuity of patients with acute cerebral infarction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114506
Enrollment
Unknown
Registered
2025-12-14
Start date
2024-07-18
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Observation group (Delipid Extracossoseal Lipoprotein filter from Plasma):None

Sponsors

Shanghai Jing’an District Shibei Hospital, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria for Acute ischemic stroke in the clinical diagnosis and treatment guidelines; 2) No visual field defect or lateral neglect, no other serious internal or surgical diseases, and cooperation in examination. 3) There is no unconscious disorder, and the patient can understand and cooperate with the ophthalmic examination.

Exclusion criteria

Exclusion criteria: 1) Consciousness disorder 2) Cerebral hemorrhage 3) Previous history of mental illness; 4) Severe insufficiency of heart, lung, kidney and other functions; 5) Malignant tumor 6) Active infection 7) Death or inability to complete the follow-up visit.

Design outcomes

Primary

MeasureTime frame
Best corrected visual acuity; optical coherence tomography angiography,OCTA;vessel density,VD;The shape and size of foveal avascular zone(FAZ);

Secondary

MeasureTime frame
perfusion density,PD;retinal nerve fiberlayer,RNFL; subfoveal choroidal thickness,SFChT;

Countries

China

Contacts

Public ContactNing Li

Shanghai Jing’an District Shibei Hospital, Shanghai

1029729094@qq.com+86 137 6452 3601

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026